2026 NPPES data Allergy & Immunology Physician NPI 1194119305 MD
Verify on CMS →

ROSHINI MULLAKARY, MD

Allergy & Immunology Physician in MAMARONECK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
238
Medicare Part D claims · 53 beneficiaries · Allergy & Immunology Physician avg: 764
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.5824/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$146.56
8 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ROSHINI MULLAKARY, MD is a Allergy & Immunology Physician ([object Object]) practicing in MAMARONECK, New York with a Medicare Part D prescribing footprint of 238 claims across 53 beneficiaries — 41% brand-name prescribing . Their CMS MIPS Final Score of 91.5824/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $146.56 across 8 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ROSHINI MULLAKARY, MD reported a CMS MIPS final score of 91.5824 out of 100, above the 83.1 national average, and filed 238 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

ROSHINI MULLAKARY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

ROSHINI MULLAKARY, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 03/25/2015

NPI 1194119305

Primary specialty

Allergy & Immunology Physician

Niche

3,390 US NPIs in this specialty

Medicare Part D claims

238 69% vs specialty avg

2023 prescription claims

Specialty avg: 764

MIPS final score

91.5824/100 8.482400000000013% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Allergy & Immunology Physician compares to other specialties among New York providers

New York providers

Allergy & Immunology Physician share within New York

1. Allergy & Immunology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Allergy & Immunology Physician share within New York

Medicare quality performance — MIPS

ROSHINI MULLAKARY, MD's 2023 MIPS final score plotted against the Allergy & Immunology Physician national average

High performer (top quartile)
MIPS Final Score
91.5824/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Allergy & Immunology Physician) — 91.5824/100 vs national avg 83.1

0%100%National avg83%91.6%
MIPS final score (Allergy & Immunology Physician) — 91.5824/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROSHINI MULLAKARY, MD is a Allergy & Immunology Physician provider practicing in MAMARONECK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1194119305. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROSHINI MULLAKARY, MD appears in the CMS NPPES registry as a Allergy & Immunology Physician provider holding MD credentials at 1600 HARRISON AVE STE 304, MAMARONECK, NY, 10543, with a listed phone of (914) 777-1179. NPI 1194119305 was issued on 03/25/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MULLAKARY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 238 prescription claims written by this provider, covering 53 Medicare beneficiaries and totaling roughly $156K in drug spend, split 41% brand-name and 59% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.5824/100 for the 2023 performance year (Quality 90.0969), compared with the national average of 83.1.

Allergy & Immunology Physician is a narrow specialty nationwide, with 3,390 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1600 HARRISON AVE STE 304
MAMARONECK, NY 10543

Provider Details

NPI 1194119305
Specialty Allergy & Immunology Physician
Credentials MD
Gender Female
NPI Issued 03/25/2015

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.5824
Final Score
Avg: 83.1
90.0969
Quality

Reporting: Group practice

Hospital and facility affiliations

Facilities where ROSHINI MULLAKARY, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

WESTCHESTER HEALTH MEDICAL PC
MAMARONECK, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROSHINI MULLAKARY, MD. Source: openpaymentsdata.cms.gov.

Total received

$147

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ROSHINI MULLAKARY, MD. To verify ROSHINI MULLAKARY, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ROSHINI MULLAKARY, MD — brand share 41.0%
Specialty average (est.)

41% brand-name claims vs 59% generic, on 238 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

238
Total Claims
$156K
Total Drug Cost
53
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
412
Total Day Supply
11,684
Brand vs Generic
41% brand / 59% generic
Brand Drug Cost
$150K
Generic Drug Cost
$7K

Patient Demographics

Average Patient Age
71.5 years
Avg HCC Risk Score
0.94
Gender Split
70% female / 30% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Montelukast Sodium
33
Azelastine Hcl
27
Albuterol Sulfate Hfa
Albuterol Sulfate
14
Dupixent Syringe
Dupilumab
13
Symbicort
Budesonide/Formoterol Fumarate
13
Fluticasone Propionate
12
Advair Hfa
Fluticasone Propion/Salmeterol
11
Hydroxyzine Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Allergy & Immunology Physician Overview

How ROSHINI MULLAKARY, MD fits within the Allergy & Immunology Physician landscape nationally.

3,390
Allergy & Immunology Physician Providers in US
52
States with Allergy & Immunology Physician
764
Avg Claims per Provider

ROSHINI MULLAKARY, MD's 238 claims are below the specialty average of 764.

Nearby Allergy & Immunology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as MULLAKARY.

Compare Allergy & Immunology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROSHINI MULLAKARY, MD's specialty?
ROSHINI MULLAKARY, MD specializes in Allergy & Immunology Physician and practices in MAMARONECK, New York. Credentials: MD.
How much does ROSHINI MULLAKARY, MD prescribe under Medicare Part D?
In 2023, ROSHINI MULLAKARY, MD wrote 238 Medicare Part D claims totaling $156K in drug costs for 53 beneficiaries.
What is ROSHINI MULLAKARY, MD's Medicare quality score?
ROSHINI MULLAKARY, MD has a CMS MIPS Final Score of 91.5824/100 (Quality: 90.0969). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ROSHINI MULLAKARY, MD located?
ROSHINI MULLAKARY, MD is located at 1600 HARRISON AVE STE 304, MAMARONECK, NY, 10543. Phone: (914) 777-1179.
What is ROSHINI MULLAKARY, MD's NPI number?
ROSHINI MULLAKARY, MD's National Provider Identifier (NPI) is 1194119305, issued on 03/25/2015.
Does ROSHINI MULLAKARY, MD prescribe more brand-name or generic drugs?
ROSHINI MULLAKARY, MD's prescribing is 41% brand-name and 59% generic drugs by claim count, with $150K in brand drug costs.
How many Allergy & Immunology Physician providers are there in the US?
There are 3,390 Allergy & Immunology Physician providers across 52 states in the US. The average Allergy & Immunology Physician provider writes 764 Medicare Part D claims per year.
What drugs does ROSHINI MULLAKARY, MD prescribe most often?
Based on 2023 Medicare Part D data, ROSHINI MULLAKARY, MD's most frequently prescribed drugs include Montelukast Sodium, Azelastine Hcl, Albuterol Sulfate Hfa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROSHINI MULLAKARY, MD accept Medicare?
ROSHINI MULLAKARY, MD appears in CMS Medicare data with 238 Part D claims and 53 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROSHINI MULLAKARY, MD's credentials?
ROSHINI MULLAKARY, MD's NPI is 1194119305 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology